OTCMLTGHY
Market cap1.27bUSD
Dec 23, Last price
3.52USD
1D
-1.68%
1Q
-5.51%
Jan 2017
-62.92%
Name
Life Healthcare Group Holdings Ltd
Chart & Performance
Profile
Life Healthcare Group Holdings Limited, together with its subsidiaries, operates private hospitals in South Africa, Canada, the United Kingdom, rest of Europe, and Internationally. It operates through two segments, Hospitals and Complementary Services; and Healthcare Services. The company provides range of acute hospitals and complementary services; Life Esidimeni services, such as chronic mental healthcare, frail care rehabilitation, step-down care, correctional services, and primary healthcare and substance abuse recovery programs; and life employee health solutions, including on-site occupational and primary healthcare services and employee wellness programs. It also offers services in the areas of diagnostics, mental health, acute rehabilitation, renal dialysis, oncology, cardiology, neurology, orthopedic, pediatric, dermatology, ophthalmology, gynecology, and obstetric. In addition, the company provides diagnostic imaging services; magnetic resonance imaging and computerized tomography scanners; develops, manufactures, and distributes radiopharmaceuticals for use in positron emission tomography-computerized tomography (PET-CT) diagnostics. The company was formerly known as Afrox Healthcare Limited and changed its name to Life Healthcare Group Holdings Limited in January 2005. Life Healthcare Group Holdings Limited was founded in 1983 and is headquartered in Johannesburg, South Africa.
Valuation
Title ZAR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑09 | 2023‑09 | 2022‑09 | 2021‑09 | 2020‑09 | 2019‑09 | 2018‑09 | 2017‑09 | 2016‑09 | 2015‑09 | |
Income | ||||||||||
Revenues | 25,519,000 12.71% | 22,641,000 -19.73% | 28,206,000 4.91% | |||||||
Cost of revenue | 9,148,000 | 18,282,000 | 10,092,000 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 16,371,000 | 4,359,000 | 18,114,000 | |||||||
NOPBT Margin | 64.15% | 19.25% | 64.22% | |||||||
Operating Taxes | 538,000 | 483,000 | 768,000 | |||||||
Tax Rate | 3.29% | 11.08% | 4.24% | |||||||
NOPAT | 15,833,000 | 3,876,000 | 17,346,000 | |||||||
Net income | 4,827,000 1,728.41% | 264,000 -82.76% | 1,531,000 -12.71% | |||||||
Dividends | (9,472,000) | (616,000) | (587,000) | |||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | (277,000) | (121,000) | 3,249,000 | |||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 1,027,000 | 2,179,000 | 1,561,000 | |||||||
Long-term debt | 4,543,000 | 12,126,000 | 14,619,000 | |||||||
Deferred revenue | 410,000 | |||||||||
Other long-term liabilities | 674,000 | 2,118,000 | 425,000 | |||||||
Net debt | 3,108,000 | 13,453,000 | 12,907,000 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 3,723,000 | 4,670,000 | 4,232,000 | |||||||
CAPEX | (1,338,000) | (1,213,000) | (2,348,000) | |||||||
Cash from investing activities | 16,664,000 | (2,933,000) | (2,703,000) | |||||||
Cash from financing activities | (19,622,000) | (2,628,000) | (1,407,000) | |||||||
FCF | 34,295,000 | (10,807,000) | 16,475,000 | |||||||
Balance | ||||||||||
Cash | 2,462,000 | 846,000 | 2,802,000 | |||||||
Long term investments | 6,000 | 471,000 | ||||||||
Excess cash | 1,186,050 | 1,862,700 | ||||||||
Stockholders' equity | 11,149,000 | 15,894,000 | 17,025,000 | |||||||
Invested Capital | 17,422,950 | 36,596,000 | 32,317,300 | |||||||
ROIC | 58.62% | 11.25% | 54.62% | |||||||
ROCE | 81.44% | 11.91% | 50.39% | |||||||
EV | ||||||||||
Common stock shares outstanding | 1,454,020 | 363,504 | ||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | 17,645,000 | 5,485,000 | 20,327,000 | |||||||
EV/EBITDA | ||||||||||
Interest | 422,000 | 578,000 | 644,000 | |||||||
Interest/NOPBT | 2.58% | 13.26% | 3.56% |